According to Horizon Therapeutics 's latest financial reports the company's total debt is $2.55 B. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2022-12-31 | $2.56 B | -0.33% |
2021-12-31 | $2.57 B | 156.26% |
2020-12-31 | $1.00 B | -25.83% |
2019-12-31 | $1.35 B | -28.67% |
2018-12-31 | $1.89 B | -0.26% |
2017-12-31 | $1.90 B | 5.21% |
2016-12-31 | $1.80 B | 57.84% |
2015-12-31 | $1.14 B | 231.43% |
2014-12-31 | $0.34 B | 211.93% |
2013-12-31 | $0.11 B | 126.97% |
2012-12-31 | $48.8 M | 151.06% |
2011-12-31 | $19.43 M | -32.36% |
2010-12-31 | $28.73 M | 260.13% |
2009-12-31 | $7.98 M | -59.44% |
2008-12-31 | $19.67 M |
Company | Total debt | differencediff. | Country |
---|---|---|---|
Pfizer PFE | $70.84 B | 2,670.13% | ๐บ๐ธ USA |
Amgen AMGN | $64.61 B | 2,426.45% | ๐บ๐ธ USA |
Merck MRK | $35.05 B | 1,270.70% | ๐บ๐ธ USA |
AstraZeneca AZN | $28.62 B | 1,019.16% | ๐ฌ๐ง UK |
Dr. Reddy's RDY | $0.23 B | -90.68% | ๐ฎ๐ณ India |